GlassScriptPhysician profile
Bruce P Page
NPI 1972567378
$5,051.41
in general payments reported to CMS, 2019-2025
42 companies · $1,042 in 2025
The $1,042 reported for 2025 was more than what 87% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $440 · 2020: $486 · 2021: $382 · 2022: $711 · 2023: $941 · 2024: $1,051 · 2025: $1,042.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,013 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,013.08 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $681.64 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $665.35 | 2019-2025 | Bexsero, Shingrix, Trelegy Ellipta |
| Lilly USA, LLC | $659.89 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $533.48 | 2019-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $257.17 | 2021-2025 | |
| Abbott Laboratories | $226.22 | 2019-2025 | Freestyle Libre 3, Afinion 2, Proclaim |
| Astellas Pharma US INC | $185.35 | 2023-2025 | Veozah |
| Merck Sharp & Dohme LLC | $182.28 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Gilead Sciences, INC. | $154.25 | 2019-2022 | |
| Pfizer INC. | $133.55 | 2019-2025 | |
| Allergan, INC. | $123.14 | 2019-2020 | |
| Genzyme Corporation | $116.15 | 2025 | |
| Idorsia Pharmaceuticals US INC | $95.95 | 2022-2023 | Quviviq |
| Dynavax Technologies Corporation | $92.52 | 2021-2023 | Heplisav-B |
| Teva Pharmaceuticals USA, INC. | $90.75 | 2020-2025 | Austedo Xr |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Page listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.